Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study

Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study

Abstract Background OnabotulinumtoxinA (BOTOX®, Allergan plc, Dublin, Ireland) is approved for the preventive treatment of headaches in adult patients with chronic migraine (CM) in Australia by the country’s reimbursement mechanism for medicines, the Pharmaceutical Benefits Scheme (PBS). To our know...

Full description

Bibliographic Details
Main Authors: Catherine Stark, Richard Stark, Nicole Limberg, Julian Rodrigues, Dennis Cordato, Raymond Schwartz, Robert Jukic
Format: Article
Language:English
Published: BMC 2019-07-01
Series:The Journal of Headache and Pain
Subjects:
Migraine disorders
Headache
OnabotulinumtoxinA
Australia
Retrospective studies
Codeine
Online Access:http://link.springer.com/article/10.1186/s10194-019-1030-z

Internet

http://link.springer.com/article/10.1186/s10194-019-1030-z

Similar Items